Gara Jalqabaatti › Duchenne Muscular Dystrophy
Qorannoo klinikaalii Duchenne Muscular Dystrophy Ameerikaa Keessatti hirmaatuu
Qorannoo 26 Duchenne Muscular Dystrophy f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Little Rock, ARQorannoo 7
- Chicago, ILQorannoo 5
- Durham, NCQorannoo 5
- Washington, DCQorannoo 5
- Sacramento, CAQorannoo 5
- Gainesville, FLQorannoo 5
- Boston, MAQorannoo 5
- Nashville, TNQorannoo 4
- Columbus, OHQorannoo 4
- Seattle, WAQorannoo 3
- Mountain View, CAQorannoo 3
- St. Louis, MOQorannoo 3
- Los Angeles, CAQorannoo 3
- Norfolk, VAQorannoo 3
- Cincinnati, OHQorannoo 3
- Portland, ORQorannoo 3
Naannoon
- ArkansasQorannoo 7
- CaliforniaQorannoo 6
- Distaarikii KoloombiyaaQorannoo 5
- FloridaQorannoo 5
- IllinoisQorannoo 5
- MassachusettsQorannoo 5
- MissouriQorannoo 3
- New YorkQorannoo 4
- North CarolinaQorannoo 6
- OhioQorannoo 5
- OregonQorannoo 3
- PennsylvaniaQorannoo 4
- TennesseeQorannoo 4
- TexasQorannoo 5
- VirginiaQorannoo 4
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 7 hanga 11 · Dhiroota · Haaromfame 28-Ful-2026 · NCT07160634Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 2 fi ol · Dhiroota · Haaromfame 24-Ful-2026 · NCT06564974A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT04626674Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 8 hanga 18 · Dhiroota · Haaromfame 24-Hag-2026 · NCT07172971The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
Namoota walitti qabaa jiraQorannoo ilaalaa
0 Days – 3 Years · Dhiroota · Haaromfame 19-Hag-2026 · NCT07092540Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Namoota walitti qabaa jira
Umuriin 6 fi ol · Dhiroota · Haaromfame 17-Hag-2026 · NCT07766980Once Weekly Infant Corticosteroid Trial for DMD
Namoota walitti qabaa jiraSadarkaa 4
1 Month – 30 Months · Dhiroota · Haaromfame 14-Hag-2026 · NCT05412394Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07674758A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 0 hanga 17 · Dhiroota · Haaromfame 08-Ado-2026 · NCT06138639A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 6 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT07127978PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 7 · Dhiroota · Haaromfame 23-Wax-2026 · NCT07429240Duchenne Electronic Health Record Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT07609394Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 4 hanga 18 · Dhiroota · Haaromfame 27-Cam-2026 · NCT07608432Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 10 fi ol · Dhiroota · Haaromfame 22-Cam-2026 · NCT06124196Vasodilator and Exercise Study for DMD (VASO-REx)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 6 fi ol · Dhiroota · Haaromfame 15-Cam-2026 · NCT06290713The Duchenne Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 08-Cam-2026 · NCT02069756Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 09-Elb-2026 · NCT06839469Urinary Titin Biomarker in DMD
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 2 hanga 10 · Dhiroota · Haaromfame 08-Elb-2026 · NCT07332013Trial of Cell Based Therapy for DMD
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Bit-2026 · NCT06692426Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 4 hanga 18 · Dhiroota · Haaromfame 15-Mud-2025 · NCT04906460Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 24-Sad-2025 · NCT05016908Biomarker Development for Muscular Dystrophies
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 5 fi ol · Saalaa hunda · Haaromfame 24-Sad-2025 · NCT05019625Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 10 fi ol · Dhiroota · Haaromfame 06-Sad-2025 · NCT06093100Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 5 hanga 62 · Dhiroota · Haaromfame 15-Onk-2025 · NCT01484678DMD Voice: Qualitative Interviews With Patients and Caregivers
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 10 fi ol · Dhiroota · Haaromfame 30-Elb-2025 · NCT06925269Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.